Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cervical malignancies.

T V Sedlacek1, K J Owens

  • 1Pennsylvania Hospital, Department of Gynecologic Oncology, Philadelphia 19107.

Current Opinion in Obstetrics & Gynecology
|February 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cervical cancer screening: what is cost-effectiveness?

Journal of lower genital tract disease·2015
Same author

Monitoring styles in women at risk for cervical cancer: implications for the framing of health-relevant messages.

Annals of behavioral medicine : a publication of the Society of Behavioral Medicine·2008
Same author

Cost-effectiveness of methods to enhance sensitivity of Papanicolaou testing.

JAMA·1999
Same author

Advances in the diagnosis and treatment of human papillomavirus infections.

Clinical obstetrics and gynecology·1999
Same author

Colposcopic guidance for LOOP.

The Journal of reproductive medicine·1999
Same author

Cervicography screening for cervical cancer among 8460 women in a high-risk population.

American journal of obstetrics and gynecology·1999

This review covers squamous cell carcinoma of the cervix, including histopathology, hormonal studies, and immunologic staging. It examines serum squamous cell antigen and treatment options for advanced or recurrent cervical cancers.

Area of Science:

  • Gynecologic Oncology
  • Pathology
  • Immunology

Background:

  • Squamous cell carcinoma of the cervix remains a significant health concern.
  • Advances in understanding its biology and treatment are crucial.

Purpose of the Study:

  • To review recent literature (August 1989-July 1990) on squamous cell carcinoma of the cervix.
  • To discuss histopathologic findings, hormonal receptor studies, and immunologic staging.
  • To evaluate clinical applications of serum squamous cell antigen and treatment strategies for advanced/recurrent disease.

Main Methods:

  • Comprehensive literature review of articles published between August 1989 and July 1990.
  • Analysis of studies on histopathology, hormonal receptors, and immunologic staging.
  • Review of clinical data on serum squamous cell antigen and treatment outcomes.

Related Experiment Videos

Main Results:

  • New histopathologic findings and hormonal receptor studies are discussed.
  • An immunologic staging system based on host immunocompetence is presented.
  • Clinical applications of serum squamous cell antigen and treatment outcomes for advanced/recurrent cervical cancer are reviewed.

Conclusions:

  • Treatment decisions for advanced or recurrent cervical cancer depend on the clinical setting, with options including radiation, chemotherapy, or ultraradical surgery.
  • Early studies suggest potential for combination therapies in complex cases.
  • No definitive conclusion on the optimal treatment modality (surgery, radiation, combined) was reached from the reviewed literature.